Under the transaction terms, BD shareholders received one share of Embecta stock for every five shares of BD that they held as of March 22. The Embecta spinoff severs all financial ties to BD, which ...

View Embecta Corporation EMBC stock quote prices, financial information, real-time forecasts, and company news from CNN.

Parsippany-based global diabetes technology leader Embecta plans to acquire medical device maker Owen Mumford in a deal worth $200 million. In a March 19 press release, the former Becton, Dickinson ...

The acquisition positions Embecta to enter the fast-growing drug-delivery device market and accelerate its shift to a broader medical supplies company. Adds a differentiated drug-delivery platform ...

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

The January ribbon cutting at embecta‘s new global headquarters in Parsippany was the latest step for one of the world’s largest pure-play diabetes management companies. “It was a really important ...

Shares of Embecta (EMBC) have been trading at multi-year lows as investors fear the overhang of GLP-1 success, with Embecta posting flattish sales at best, yet being able to post strong margins. That ...

An announcement from Embecta Corporation ( (EMBC)) is now available. On May 15, 2026, Embecta completed its acquisition of Owen Mumford Holdings Limited, following a March 19, 2026 purchase agreement ...

Embecta Corp. agreed to acquire Owen Mumford Holdings Ltd. for up to £150 million (US$200 million) in a bid to boost its drug-delivery platforms and medical device technologies. Specifically, the deal ...

Robbins LLP is Investigating Allegations that Embecta Corp. (EMBC) Misled Investors Regarding its Business Prospects According to the complaint, during the class period, defendants provided investors ...

Embecta Corp. (NASDAQ:EMBC) is one of the best cheap stocks with huge upside potential. On May 23, BTIG analyst Marie Thibault lowered the firm’s price target on Embecta Corp. (NASDAQ:EMBC) to $25 ...

Embecta Corp. (NASDAQ:EMBC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On May 23, Mizuho lowered the firm’s price target on Embecta Corp. (NASDAQ:EMBC) to $13 from $15, ...